Financials Merchavia Holdings and Investments Ltd
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.5 ILa | 0.00% | +1.24% | -13.76% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 21.39 | 20.64 | 55.5 | 57.32 | 27.02 | 15.87 |
Enterprise Value (EV) 1 | 16.62 | 17.82 | 46.44 | 49.89 | 22.77 | 13.68 |
P/E ratio | 34.2 x | 4.66 x | 17.6 x | 9.97 x | -7.9 x | -0.98 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.39 x | 2.83 x | 7.47 x | 5.4 x | 6.49 x | 8.59 x |
EV / Revenue | 6.52 x | 2.44 x | 6.25 x | 4.7 x | 5.47 x | 7.4 x |
EV / EBITDA | 13.1 x | 3.67 x | 10.4 x | 6.97 x | 15.5 x | -65.4 x |
EV / FCF | 7.19 x | 5.12 x | 7.72 x | 8.64 x | 13.6 x | 25.1 x |
FCF Yield | 13.9% | 19.5% | 13% | 11.6% | 7.33% | 3.98% |
Price to Book | 0.91 x | 0.65 x | 1.49 x | 1.2 x | 0.62 x | 0.55 x |
Nbr of stocks (in thousands) | 12,511 | 13,232 | 14,800 | 16,425 | 16,425 | 16,799 |
Reference price 2 | 1.710 | 1.560 | 3.750 | 3.490 | 1.645 | 0.9450 |
Announcement Date | 28/03/19 | 26/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 31/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.549 | 7.304 | 7.426 | 10.61 | 4.161 | 1.848 |
EBITDA 1 | 1.264 | 4.856 | 4.466 | 7.155 | 1.469 | -0.209 |
EBIT 1 | 1.256 | 4.852 | 4.46 | 7.147 | 1.461 | -0.221 |
Operating Margin | 49.27% | 66.43% | 60.06% | 67.37% | 35.11% | -11.96% |
Earnings before Tax (EBT) 1 | 0.876 | 4.553 | 2.988 | 5.852 | -3.607 | -16.23 |
Net income 1 | 0.876 | 4.553 | 2.988 | 5.852 | -3.607 | -16.23 |
Net margin | 34.37% | 62.34% | 40.24% | 55.16% | -86.69% | -878.3% |
EPS 2 | 0.0500 | 0.3347 | 0.2125 | 0.3500 | -0.2083 | -0.9600 |
Free Cash Flow 1 | 2.312 | 3.478 | 6.016 | 5.777 | 1.67 | 0.5449 |
FCF margin | 90.72% | 47.62% | 81.02% | 54.45% | 40.14% | 29.48% |
FCF Conversion (EBITDA) | 182.94% | 71.62% | 134.72% | 80.74% | 113.69% | - |
FCF Conversion (Net income) | 263.97% | 76.39% | 201.36% | 98.72% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 28/03/19 | 26/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 31/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 4.77 | 2.83 | 9.06 | 7.43 | 4.25 | 2.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 2.31 | 3.48 | 6.02 | 5.78 | 1.67 | 0.54 |
ROE (net income / shareholders' equity) | 4.09% | 17% | 8.89% | 13.8% | -7.78% | -44% |
ROA (Net income/ Total Assets) | 3.52% | 11% | 8.04% | 10.3% | 1.93% | -0.36% |
Assets 1 | 24.87 | 41.42 | 37.17 | 57.08 | -186.6 | 4,459 |
Book Value Per Share 2 | 1.880 | 2.400 | 2.510 | 2.910 | 2.670 | 1.720 |
Cash Flow per Share 2 | 0.3800 | 0.2300 | 0.6100 | 0.4500 | 0.2400 | 0.1300 |
Capex 1 | 0 | - | 0.02 | - | 0.01 | 0.02 |
Capex / Sales | 0.12% | - | 0.31% | - | 0.22% | 0.81% |
Announcement Date | 28/03/19 | 26/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 31/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.76% | 3.71M | |
+52.32% | 55.7B | |
+41.08% | 39.91B | |
-5.24% | 39.57B | |
-5.56% | 28.16B | |
+15.94% | 26.3B | |
-20.99% | 18.94B | |
+33.22% | 12.17B | |
+26.43% | 12.12B | |
+2.44% | 12.12B |
- Stock Market
- Equities
- MRHL Stock
- Financials Merchavia Holdings and Investments Ltd